Animal Disease Outbreak Monitoring Market Report 2026

The animal disease outbreak monitoring market size has grown rapidly in recent years. It will grow from $2.68 billion in 2025 to $2.96 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising incidence of zoonotic and livestock diseases, increasing government focus on animal health surveillance programs, growing adoption of molecular diagnostic technologies, expanding livestock farming and animal trade activities, increasing investments in veterinary healthcare infrastructure.

The animal disease outbreak monitoring market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion by 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing integration of AI based disease prediction systems, rising demand for cloud based outbreak monitoring platforms, increasing adoption of next generation sequencing technologies in veterinary diagnostics, expanding use of connected sensors and smart monitoring devices, growing focus on antimicrobial resistance monitoring and biosecurity management. Major trends in the forecast period include increasing adoption of real time animal disease surveillance systems, growing demand for predictive outbreak monitoring platforms, rising use of epidemiological data integration tools, increasing focus on biosecurity and zoonotic disease prevention, growing implementation of rapid diagnostic and reporting technologies.

The increasing incidence of zoonotic and transboundary animal diseases is expected to propel the growth of the animal disease outbreak monitoring market going forward. Zoonotic and transboundary animal diseases are illnesses caused by pathogens that can be transmitted between animals and humans or spread rapidly across borders, posing simultaneous risks to animal health, human health, and food security. The growing prevalence of zoonotic and transboundary animal diseases is contributing to market expansion, primarily driven by intensifying interactions between wildlife and domestic livestock, as expanding agricultural activities and habitat encroachment increase cross-species contact and accelerate pathogen spillover from wild reservoirs into farmed populations. The rising occurrence of these diseases is supporting demand for outbreak monitoring systems, as early detection and real-time surveillance are critical for containing cross-species transmission, preventing large-scale outbreaks, and enabling coordinated rapid response mechanisms. For instance, in January 2025, according to the report published by the Government of Canada, a Canada-based federal authority, there were 158 rabies samples submitted in December 2024, up from 147 rabies samples submitted in November 2022. Therefore, the rising incidence of zoonotic and transboundary animal diseases is propelling the growth of the animal disease outbreak monitoring market.

Leading companies operating in the animal disease outbreak monitoring market are focusing on strengthening animal disease surveillance infrastructure through dedicated funding programs and integrated monitoring systems to enhance early detection, rapid response, and prevention of zoonotic and livestock diseases. These initiatives support data collection, diagnostic capacity, and coordinated response mechanisms across regions. For example, in November 2024, the Government of India, an India-based government department, introduced the Animal Health Security Strengthening initiative under its broader livestock health strategy, supported by funding from the World Bank. The program aims to improve disease surveillance networks, enhance laboratory diagnostic capabilities, and establish real-time monitoring systems to detect and respond to emerging animal disease outbreaks, thereby safeguarding livestock productivity and public health.

In September 2023, Mars, Incorporated, a US-based pet care company, acquired SYNLAB Vet for an undisclosed amount. The acquisition integrates SYNLAB Vet’s laboratories, rapid diagnostics, telemedicine, and digital solutions into Mars Petcare’s Science & Diagnostics division, expanding veterinary coverage and accelerating innovation across Europe. It strengthens Mars’ diagnostic portfolio by combining expertise in imaging, software, and molecular testing, enabling advanced, data-driven healthcare solutions and improved support for veterinary professionals. SYNLAB Vet is a Germany-based provider of veterinary laboratory diagnostics.

Major companies operating in the animal disease outbreak monitoring market are Merck & Co Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., GEA Group Aktiengesellschaft, Elanco Animal Health Incorporated, bioMérieux SA, IDEXX Laboratories Inc., Bio Rad Laboratories Inc., QIAGEN NV, Ceva Santé Animale SA, Virbac SA, DeLaval Holding AB, Randox Laboratories Ltd, Nedap NV, Bioneer Corporation, Afimilk Ltd, Agrolabo SpA, Innovative Diagnostics SAS, Royal GD.

North America was the largest region in the animal disease outbreak monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal disease outbreak monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the animal disease outbreak monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal disease outbreak monitoring market consists of revenues earned by entities by providing services such as real-time data integration and analytics, early warning alert systems, field sample collection and laboratory diagnostics, risk assessment, and predictive modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The animal disease outbreak monitoring market also includes sales of diagnostic test kits, data analytics platforms, and remote sensing tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.